Deep Tech Startups

Type One Energy develops stellarator fusion technology for grid-scale power generation. The company partners with energy producers to commercialize and deploy commercial fusion power plants.

5 investors

Tzafon develops machine intelligence systems focused on multimodality, high-performance compute, and continuous learning. The company serves organizations requiring advanced AI capabilities.

5 investors

Velaura develops high-performance, energy-efficient computing solutions optimized for AI and advanced computing applications. The company was founded by engineers and executives with experience from major technology firms in semiconductors, networking, and computing infrastructure.

5 investors

Velo3D manufactures metal additive manufacturing systems using laser powder bed fusion technology for industrial production. The company serves manufacturers requiring complex geometries, large-format parts, and scalable production workflows across demanding industries.

5 investors

Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery. The company has advanced lead programs in Parkinson's disease and lupus through Phase 2 clinical trials.

5 investors

VeriSilicon offers custom silicon (chip) design solutions and a portfolio of semiconductor IP, including processor IP and mixed-signal analog/digital IP. The company works with chip developers to shorten design cycles and support high-node-process volume production.

5 investors

Veritas In Silico develops AI-driven drug discovery platforms targeting RNA and nucleic acid-based therapeutics, partnering with pharmaceutical companies for small molecule and mRNA drug creation.

5 investors

VitreaLab develops light engines for augmented-reality displays, based on its proprietary Quantum Light Chip (QLC) technology that generates compact, power-efficient, high-brightness light for AR glasses. It targets manufacturers of AR display systems and waveguide-based smart glasses.

5 investors

Vividion Therapeutics develops small molecule therapeutics using a covalent-first chemoproteomics approach to identify and target previously undruggable proteins. The company operates across the full drug development spectrum from discovery to clinical development.

5 investors

Volt14 Solutions develops silicon-majority anode materials that replace conventional graphite anodes in lithium-ion battery cells, aiming to increase energy density and lower cost while remaining compatible with existing cell manufacturing infrastructure. It sells integrated, ready-to-use anode solutions to battery cell manufacturers.

5 investors

Wellumio develops axana®, a portable, energy-efficient MRI system based on its Pulsed Gradient Free Mapping (PGFM) technology, designed to detect acute stroke quickly in front-line care settings. The product targets stroke diagnostics and brain imaging workflows in medical and critical care environments.

5 investors

Wild Microbes uses synthetic biology to engineer microbes sourced from diverse wild biomes into production hosts for biomanufacturing high-performance ingredients. Its product pipeline spans emulsifiers, cleansers, vitamins, supplements, and industrial chemicals for partners seeking renewable, microbe-made inputs.

5 investors

XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.

5 investors

Yoneda Labs applies AI/ML and high-throughput experimentation (HTE) to chemical reaction optimization, including cross-coupling reactions, for the life sciences and pharmaceutical research market. The company combines chemistry research, software, and robotics to optimize synthetic reactions.

5 investors

Zeitview provides advanced inspection software for high-value infrastructure assets including solar, wind, properties, telecom, and utility infrastructure. The platform uses aerial imagery and inspections to help operators monitor asset condition and performance throughout their lifecycle, enabling better decision-making and cost efficiency in renewable energy and sustainable infrastructure.

5 investors

ZSCC designs AI silicon chips (XPU) optimized for energy efficiency in machine learning inference and training, targeting the infrastructure demands of recursive self-improvement and advanced AI systems. The company is developing both individual processor units and clustered systems for scientific discovery and model training applications.

5 investors

ZymVol uses a physics-AI computational approach combining bioinformatics, molecular modelling, and AI to model enzyme function and predict biocatalyst performance in silico. It serves R&D teams across industries to accelerate enzyme engineering and biocatalysis campaigns by prioritizing top-performing candidates before lab work.

5 investors

Zyphra is an AI research company building open foundation models based on novel architectures trained on heterogeneous compute, with a focus on intelligence efficiency and silicon performance. It offers a full-stack platform that delivers these AI models to developers, enterprises, and AI hyperscalers, giving organizations sovereign control over their AI.

5 investors

Optieum develops next-generation CAR-T cell therapies using a proprietary CAR discovery platform to optimize immune cell activation for treating solid tumors and hematological malignancies. The company engineers precision CAR constructs to enhance T-cell therapeutic efficacy.

5 investors

Metagen Therapeutics (メタジェンセラピューティクス) is a biotech venture developing fecal microbiota transplantation (FMT) therapies and medical services based on gut microbiome research, including an FMT drug candidate (MGT-006) for ulcerative colitis. Based in Japan, it operates across drug discovery and medical services and runs a stool donation platform to source raw material.

5 investors

Dioseve develops reproductive cell technology that uses a proprietary differentiation-induction method to generate oocytes and ovarian somatic cells from iPS cells. The company targets fertility and infertility challenges, aiming to help people who want to have children, particularly around age-related declines in egg and sperm function.

5 investors

Orbital Lasers develops space optical technology centered on satellite lasers, including systems aimed at addressing space debris, satellite bus, and mission instrument development. The Japanese company works in the space and deeptech sector serving the emerging NewSpace market.

5 investors

QunaSys develops algorithms and software to maximize the performance of quantum computers, aiming to make quantum computing practical for real business applications. The company also provides quantum technology consulting services.

5 investors

Modalis Therapeutics develops therapeutics using CRISPR gene-editing technology and provides its platform technology for drug development. It operates in the biotechnology sector.

5 investors